| ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group R Goel, EM Bloch, F Prenne, A Al-Riyami, E Crowe, L Dau, K Land, ... Vox Sanguinis, 2021 | 169 | 2021 |
| Hemolytic transfusion reactions SR Panch, C Montemayor Rossi's Principles of Transfusion Medicine, 543-552, 2022 | 117 | 2022 |
| Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas D Buehler, H Hardin, W Shan, C Montemayor-Garcia, PS Rush, S Asioli, ... Modern Pathology 26 (1), 54-61, 2013 | 103 | 2013 |
| The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression H Hardin, Z Guo, W Shan, C Montemayor-Garcia, S Asioli, XM Yu, ... The American journal of pathology 184 (8), 2342-2354, 2014 | 100 | 2014 |
| The role of epithelial mesenchymal transition markers in thyroid carcinoma progression C Montemayor-Garcia, H Hardin, Z Guo, C Larrain, D Buehler, S Asioli, ... Endocrine pathology 24, 206-212, 2013 | 77 | 2013 |
| In situ hybridization analysis of miR-146b-5p and miR-21 in thyroid nodules: diagnostic implications Z Guo, H Hardin, C Montemayor-Garcia, S Asioli, A Righi, F Maletta, ... Endocrine pathology 26, 157-163, 2015 | 54 | 2015 |
| Genome-wide analysis of binding sites and direct target genes of the orphan nuclear receptor NR2F1/COUP-TFI C Montemayor, OA Montemayor, A Ridgeway, F Lin, DA Wheeler, ... PLoS One 5 (1), e8910, 2010 | 54 | 2010 |
| Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers H Hardin, C Montemayor-Garcia, RV Lloyd Human pathology 44 (9), 1707-1713, 2013 | 45 | 2013 |
| ABO, Rhesus, and Kell antigens, alleles, and haplotypes in West Bengal, India D Basu, SS Datta, C Montemayor, P Bhattacharya, K Mukherjee, ... Transfusion Medicine and Hemotherapy 45 (1), 62-66, 2018 | 38 | 2018 |
| Stem cells and cancer stem-like cells in endocrine tissues RV Lloyd, H Hardin, C Montemayor-Garcia, F Rotondo, LV Syro, ... Endocrine pathology 24, 1-10, 2013 | 36 | 2013 |
| Promoting access to COVID-19 convalescent plasma in low-and middle-income countries EM Bloch, R Goel, C Montemayor, C Cohn, AAR Tobian Transfusion and Apheresis Science 60 (1), 102957, 2021 | 35 | 2021 |
| Role of percutaneous needle core biopsy in diagnosis and clinical management of renal masses R Hu, C Montemayor-Garcia, K Das Human pathology 46 (4), 570-576, 2015 | 21 | 2015 |
| Sensorineural hearing loss: potential therapies and gene targets for drug development LS Tang, FA Montemayor, C and Pereira IUBMB Life 58 (9), 525-30, 2006 | 20 | 2006 |
| Red cell genotyping precision medicine: a conference summary GA Denomme, WQ Anani, ND Avent, G Bein, LB Briggs, RC Lapadat, ... Therapeutic Advances in Hematology 8 (10), 277-291, 2017 | 18 | 2017 |
| Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project C Montemayor‐Garcia, P Karagianni, DA Stiles, EM Reese, DA Smellie, ... Transfusion 58 (11), 2693-2704, 2018 | 16 | 2018 |
| Banking with precision: transfusion medicine as a potential universal application in clinical genomics C Montemayor, PAR Brunker, MA Keller Current opinion in hematology 26 (6), 480, 2019 | 13 | 2019 |
| Encapsulated follicular variant of papillary thyroid cancer: are these tumors really benign? Z Aburjania, S Jang, C Montemayor-Garcia, RV Lloyd, DF Schneider, ... journal of surgical research 216, 138-142, 2017 | 12 | 2017 |
| Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection S Sheela, S Ito, JR Strich, M Manion, C Montemayor-Garcia, HW Wang, ... Leukemia research reports 8, 4-6, 2017 | 11 | 2017 |
| The “next generation” reference laboratory? C Montemayor‐Garcia, CM Westhoff Transfusion 58 (2), 277-279, 2018 | 10 | 2018 |
| Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics Y Gao, EB Kabotyanski, JH Shepherd, E Villegas, D Acosta, C Hamor, ... Cancer Research Communications 1 (3), 178-193, 2021 | 9 | 2021 |